Fieldview Capital Management LLC Invests $987,000 in Marsh & McLennan Companies, Inc. $MRSH

Fieldview Capital Management LLC purchased a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,322 shares of the financial services provider’s stock, valued at approximately $987,000.

Several other institutional investors have also modified their holdings of the company. Procyon Advisors LLC grew its position in shares of Marsh & McLennan Companies by 2.5% during the fourth quarter. Procyon Advisors LLC now owns 2,279 shares of the financial services provider’s stock worth $423,000 after acquiring an additional 56 shares during the last quarter. PFG Investments LLC grew its position in shares of Marsh & McLennan Companies by 3.3% during the fourth quarter. PFG Investments LLC now owns 1,758 shares of the financial services provider’s stock worth $326,000 after acquiring an additional 56 shares during the last quarter. Lindenwold Advisors INC grew its position in shares of Marsh & McLennan Companies by 0.4% during the third quarter. Lindenwold Advisors INC now owns 14,994 shares of the financial services provider’s stock worth $3,022,000 after acquiring an additional 62 shares during the last quarter. SeaCrest Wealth Management LLC grew its position in Marsh & McLennan Companies by 3.9% in the 4th quarter. SeaCrest Wealth Management LLC now owns 1,673 shares of the financial services provider’s stock valued at $306,000 after buying an additional 63 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC grew its position in Marsh & McLennan Companies by 0.7% in the 3rd quarter. Wealthcare Advisory Partners LLC now owns 9,996 shares of the financial services provider’s stock valued at $2,015,000 after buying an additional 66 shares in the last quarter. Institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Price Performance

Shares of NYSE MRSH opened at $168.67 on Monday. Marsh & McLennan Companies, Inc. has a twelve month low of $156.60 and a twelve month high of $220.32. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. The stock has a market capitalization of $81.49 billion, a price-to-earnings ratio of 21.08, a price-to-earnings-growth ratio of 2.46 and a beta of 0.62.

Marsh & McLennan Companies (NYSE:MRSH) last issued its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The company had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies’s revenue for the quarter was up 7.6% on a year-over-year basis. Equities analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at approximately $18,889,506.81. This represents a 12.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.38% of the company’s stock.

Analyst Ratings Changes

MRSH has been the subject of a number of recent analyst reports. UBS Group decreased their target price on shares of Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating for the company in a research report on Tuesday, June 9th. Barclays decreased their target price on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Mizuho decreased their target price on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research report on Monday, April 13th. Bank of America decreased their target price on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a research report on Tuesday, April 14th. Finally, Keefe, Bruyette & Woods increased their target price on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “market perform” rating in a research report on Friday, April 17th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Marsh & McLennan Companies has a consensus rating of “Hold” and a consensus price target of $200.19.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.